Literature DB >> 23215787

Morphine administration modulates expression of Argonaute 2 and dopamine-related transcription factors involved in midbrain dopaminergic neurons function.

D García-Pérez1, F Sáez-Belmonte, M L Laorden, C Núñez, M V Milanés.   

Abstract

BACKGROUND AND
PURPOSE: Alterations in transcription factors that regulate the development and maintenance of dopamine (DA) neurons (such as Nurr1 and Pitx3) play an important role in the pathogenesis of addiction diseases. We have examined the effects of acute and chronic morphine and morphine withdrawal on TH expression and activity as well as expression of Nurr1, Pitx3 and Ago2 in the ventral tegmental area (VTA) and nucleus accumbens (NAc) of the rat. EXPERIMENTAL APPROACH: Rats were injected acutely with morphine and decapitated 1 or 2 h later. Another set of rats were made dependent on morphine by implantation of two morphine pellets. Precipitated withdrawal was induced by injection of naloxone. Ago2, Pitx3, Nurr1, total TH (tTH), TH phosphorylated at Ser31 and at Ser40, and 3,4-Dihydroxyphenylacetic acid, and DA determination in the VTA and/or NAc were measured using immunoblotting, HPLC and immunofluorescence. KEY
RESULTS: Acute morphine produced a marked increase in TH activity and DA turnover in the NAc, concomitantly with increased Nurr1 and Pitx3 expression in the VTA. In contrast, precipitated morphine withdrawal decreased TH activation, TH expression and did not increase DA turnover in the NAc. These effects paralleled decreases in Ago2 expression, which was accompanied by increased Nurr1 and Pitx3, TH activity and normalized TH protein levels in the VTA. CONCLUSIONS AND IMPLICATIONS: The combined decrease in Ago2 and increases in Nurr1 and Pitx3 might represent some of the mechanisms that served to protect against accumbal TH regulation observed in morphine withdrawn rats, which may be critical for DA bioavailability to influence behaviour.
© 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23215787      PMCID: PMC3623059          DOI: 10.1111/bph.12083

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

Review 1.  Molecular basis of long-term plasticity underlying addiction.

Authors:  E J Nestler
Journal:  Nat Rev Neurosci       Date:  2001-02       Impact factor: 34.870

2.  Guide to Receptors and Channels (GRAC), 5th edition.

Authors:  Stephen P H Alexander; Alistair Mathie; John A Peters
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

3.  A guided tour into subcellular colocalization analysis in light microscopy.

Authors:  S Bolte; F P Cordelières
Journal:  J Microsc       Date:  2006-12       Impact factor: 1.758

4.  Chronic cocaine administration modulates the expression of transcription factors involved in midbrain dopaminergic neuron function.

Authors:  D Leo; U di Porzio; G Racagni; M A Riva; F Fumagalli; C Perrone-Capano
Journal:  Exp Neurol       Date:  2006-10-27       Impact factor: 5.330

5.  Pitx3 potentiates Nurr1 in dopamine neuron terminal differentiation through release of SMRT-mediated repression.

Authors:  Frank M J Jacobs; Susan van Erp; Annemarie J A van der Linden; Lars von Oerthel; J Peter H Burbach; Marten P Smidt
Journal:  Development       Date:  2009-01-14       Impact factor: 6.868

6.  Morphine regulates dopaminergic neuron differentiation via miR-133b.

Authors:  Fatima Macho Sanchez-Simon; Xiao Xiao Zhang; Horace H Loh; Ping-Yee Law; Raquel E Rodriguez
Journal:  Mol Pharmacol       Date:  2010-08-17       Impact factor: 4.436

7.  Reversal of prolonged dopamine inhibition of dopaminergic neurons of the ventral tegmental area.

Authors:  Sudarat Nimitvilai; Mark S Brodie
Journal:  J Pharmacol Exp Ther       Date:  2010-02-17       Impact factor: 4.030

8.  A MicroRNA feedback circuit in midbrain dopamine neurons.

Authors:  Jongpil Kim; Keiichi Inoue; Jennifer Ishii; William B Vanti; Sergey V Voronov; Elizabeth Murchison; Gregory Hannon; Asa Abeliovich
Journal:  Science       Date:  2007-08-31       Impact factor: 47.728

9.  Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons.

Authors:  Dong-Youn Hwang; Sunghoi Hong; Joo-Won Jeong; Sangdun Choi; Hansoo Kim; Jangwoo Kim; Kwang-Soo Kim
Journal:  J Neurochem       Date:  2009-09-24       Impact factor: 5.372

10.  Post-transcriptional regulation of tyrosine hydroxylase expression in adrenal medulla and brain.

Authors:  A William Tank; Lu Xu; Xiqun Chen; Pheona Radcliffe; Carol R Sterling
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

View more
  11 in total

Review 1.  MicroRNAs in neuronal communication.

Authors:  Guilherme Shigueto Vilar Higa; Erica de Sousa; Lais Takata Walter; Erika Reime Kinjo; Rodrigo Ribeiro Resende; Alexandre Hiroaki Kihara
Journal:  Mol Neurobiol       Date:  2014-01-03       Impact factor: 5.590

Review 2.  MicroRNAs and synaptic plasticity--a mutual relationship.

Authors:  Ayla Aksoy-Aksel; Federico Zampa; Gerhard Schratt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-09-26       Impact factor: 6.237

3.  Novel biomarkers to assess in utero effects of maternal opioid use: First steps toward understanding short- and long-term neurodevelopmental sequelae.

Authors:  Laura Goetzl; Tara Thompson-Felix; Nune Darbinian; Nana Merabova; Salim Merali; Carmen Merali; Kathryne Sanserino; Tamara Tatevosian; Bruno Fant; Mathieu E Wimmer
Journal:  Genes Brain Behav       Date:  2019-06-11       Impact factor: 3.449

4.  Multi-chemokine receptor antagonist RAP-103 inhibits opioid-derived respiratory depression, reduces opioid reinforcement and physical dependence, and normalizes opioid-induced dysregulation of mesolimbic chemokine receptors in rats.

Authors:  Angela R Bongiovanni; Pingwei Zhao; Saadet Inan; Sonita Wiah; Aryan Shekarabi; Daniel J Farkas; Mia N Watson; Mathieu E Wimmer; Michael R Ruff; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2022-07-11       Impact factor: 4.852

5.  Acute Morphine, Chronic Morphine, and Morphine Withdrawal Differently Affect Pleiotrophin, Midkine, and Receptor Protein Tyrosine Phosphatase β/ζ Regulation in the Ventral Tegmental Area.

Authors:  Daniel García-Pérez; M Luisa Laorden; M Victoria Milanés
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

6.  Regulation of Pleiotrophin, Midkine, Receptor Protein Tyrosine Phosphatase β/ζ, and Their Intracellular Signaling Cascades in the Nucleus Accumbens During Opiate Administration.

Authors:  Daniel García-Pérez; María Luisa Laorden; María Victoria Milanés
Journal:  Int J Neuropsychopharmacol       Date:  2015-07-11       Impact factor: 5.176

7.  Orphan nuclear receptor NR4A2 inhibits hepatic stellate cell proliferation through MAPK pathway in liver fibrosis.

Authors:  Pengguo Chen; Jie Li; Yan Huo; Jin Lu; Lili Wan; Bin Li; Run Gan; Cheng Guo
Journal:  PeerJ       Date:  2015-12-21       Impact factor: 2.984

8.  Levels of Cocaine- and Amphetamine-Regulated Transcript in Vagal Afferents in the Mouse Are Unaltered in Response to Metabolic Challenges.

Authors:  Xuefeng Yuan; Ying Huang; Sarita Shah; Hua Wu; Laurent Gautron
Journal:  eNeuro       Date:  2016-10-05

Review 9.  Noncoding RNA Regulation of Dopamine Signaling in Diseases of the Central Nervous System.

Authors:  William T Carrick; Brandi Burks; Murray J Cairns; Jannet Kocerha
Journal:  Front Mol Biosci       Date:  2016-10-25

10.  The transcription factor Nurr1 is upregulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice.

Authors:  Valeria Valsecchi; Marina Boido; Francesca Montarolo; Michela Guglielmotto; Simona Perga; Serena Martire; Santina Cutrupi; Andrea Iannello; Nadia Gionchiglia; Elena Signorino; Andrea Calvo; Giuseppe Fuda; Adriano Chiò; Antonio Bertolotto; Alessandro Vercelli
Journal:  Dis Model Mech       Date:  2020-05-15       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.